GNTA has much more in the pipeline than Genasense. Panic was the reason for the sell-off back in December. Then Genta released a statement that they wanted to review an amended NDA with the senior leadership from the FDA. At .0037, how can anyone afford NOT to throw a few hundred dollars at this? Talk about undervalued.
News 
Market Data 
Discover 
